donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > GMED Globus Medical > Key Indicators
GMED Globus Medical
56.140
-1.390-2.42%
Post Mkt Price
56.14000.00%
YOY
Do not show
Hide blank lines
(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31(Q3)2021/09/30
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle(D)
0.65% 390.1134 -1.62% 383.2935 -1.62% 383.2935 -3.81% 376.9472
Receivable Turnover(T)
6.58% 5.8767 17.42% 6.2598 17.42% 6.2598 15.41% 6.2179
Inventory Turnover(T)
-1.35% 1.0017 0.4% 1.0264 0.4% 1.0264 4.26% 1.0222
Fixed Assets Turnover(T)
12.49% 4.3329 15.54% 4.3753 15.54% 4.3753 17.43% 4.3696
Total Asset Rate(T)
0.23% 0.5145 7.23% 0.5269 7.23% 0.5269 6.42% 0.5454
ROIC
1.97% 8.479% 30.64% 9.188% 30.64% 9.188% 73.32% 11.931%
ROE
1.97% 8.479% 30.64% 9.188% 30.64% 9.188% 73.32% 11.931%
ROA
0.45% 7.598% 28.8% 8.205% 28.8% 8.205% 71% 10.836%
FCF to Sales
1.07% 20.201% 33.69% 22.897% 33.69% 22.897% 71.49% 24.034%
FCF to Net Income
0.85% 136.811% 11.3% 147.044% 11.3% 147.044% 6.72% 120.983%
Efficiency Ratios
ROE 5 Year Average
-- -- -7.29% 10.935% -- -- -- --
ROA 5 Year Average
-- -- -6.87% 9.878% -- -- -- --
Average 5 Years ROIC
-- -- -7.19% 10.418% -- -- -- --
Profitability Ratios TTM
Gross Margin
2.42% 74.684% 3.58% 75.032% 3.58% 75.032% 1.99% 74.692%
Operating Margin
14.89% 19.644% 38.97% 20.338% 38.97% 20.338% 74.89% 24.352%
Net Margin
0.22% 14.766% 20.12% 15.571% 20.12% 15.571% 60.69% 19.866%
EBITDA Margin
7.4% 0.2688% 22.24% 0.2763% 22.24% 0.2763% 49.93% 0.3178%
R & D Expense Ratio
2.06% 10.390% -5.14% 10.160% -5.14% 10.160% -40.81% 6.540%
Sales Expense Ratio
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Administration Expense Rate
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Financial Health Ratios
Total Assets to Common Equity
0.68% 111.948% 0.81% 112.397% 0.81% 112.397% 2.21% 111.192%
Current Ratio
-1.62% 6.4781 -9.34% 6.1679 -9.34% 6.1679 -1.46% 8.0026
Quick Ratio
-0.72% 4.5453 -8.69% 4.3456 -8.69% 4.3456 6.17% 5.9575
GrowthRatios
Growth Ratios
Revenue CAGR(3Y)
-- -- 38.89% 10.352% -- -- -- --
Revenue CAGR(5Y)
-- -- 45.36% 11.180% -- -- -- --
Net Income CAGR(3Y)
-- -- 1.33% -1.576% -- -- -- --
Net Income CAGR(5Y)
-- -- 483.05% 7.413% -- -- -- --
FCF 1 Year Growth
-- -- 86.09% 62.338% -- -- -- --
FCF CAGR(3Y)
-- -- 181.5% 21.621% -- -- -- --
FCF CAGR(5Y)
-- -- -20.54% 10.865% -- -- -- --
Currency Unit
USDUSDUSDUSD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
CEO: --
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...